Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
Zacharopoulou, P.; Marchi, E.; Ogbe, A.; Robinson, N.; Brown, H.; Jones, M.; Parolini, L.; Pace, M.; Grayson, N.; Kaleebu, P.; Rees, H.; Fidler, S.; Goulder, P.; Klenerman, P.; Frater, J.
Show abstract
Although certain individuals with HIV infection can stop antiretroviral therapy (ART) without evidence of viral load rebound, the mechanisms under-pinning post-treatment control remain unclear. Twelve individuals who had received 12 months of ART from primary HIV infection and then undertook a TI were sampled at the time of stopping therapy. Using RNA-Seq we explored gene expression in CD4 T cells to look for evidence of a mechanism that might underpin virological rebound and lead to discovery of an associated biomarker. Using independent analysis tools, genes associated with the type I interferon response were strongly associated with a delayed time to viral rebound following TI. These are the first data we are aware of that link transcriptomic signatures associated with innate immunity with control following TI. While these results need to be confirmed in larger trials, they could help define a strategy for new therapies and identify new biomarkers for remission.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Antiretroviral treatment-induced decrease in immune activation contributes to reduced susceptibility to tuberculosis in HIV-1-TB co-infected persons 93%
- Immune cell type signature discovery and random forest classification for analysis of single cell gene expression datasets 92%
- Unravelling the shared genetic mechanisms underlying 18 autoimmune diseases using a systems approach 92%
Similar papers in this journal
- Whole blood transcriptional profiles and the pathogenesis of tuberculous meningitis 93%
- HIV infection alters SARS-CoV-2 responsive immune parameters but not clinical outcomes in COVID-19 disease 93%
- The use of non-functional clonotypes as a natural calibrator for quantitative bias correction in adaptive immune receptor repertoire profiling 92%
Similar papers in this journal
- Mycobacterium tuberculosis infection associated immune perturbations correlate with antiretroviral immunity 93%
- Transcriptional response modules characterise IL-1β and IL-6 activity in COVID-19 93%
- Distinct lipid profile, low-level inflammation and increased antioxidant defense as a signature in HIV-1 elite control status 92%
Similar papers in this journal
- Comparative transcriptomic analysis of whole blood mycobacterial growth assays and tuberculosis patients' blood RNA profiles 92%
- The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors 92%
- Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2 91%
Similar papers in this journal
- Treatment with commonly used antiretroviral drugs induces a type I/III interferon signature in the gut in the absence of HIV infection 94%
- Genome profiles of lymphovascular breast cancer cells reveal multiple clonally differentiated outcomes with multi-regional LCM and G&T-seq 90%
- Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.